Comparative effects of anti-thymocyte globulin (ATGAM) vs interleukin-2receptor monoclonal antibody based induction therapy on cadaveric renal transplant outcome

被引：0
|
作者：
Lal, Sunder M. [1 ]
Gupta, Nilakshi [1 ]
Ross Jr., Gilbert [1 ]
机构：
[1] Univ of Missouri Health Science Cent, Columbia, United States
来源：
ASAIO Journal | 2000年 / 46卷 / 02期
关键词：
D O I：
10.1097/00002480-200003000-00285
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Outcome of deceased donor renal transplantation patients who underwent induction therapy with basiliximab and rabbit anti-thymocyte globulin at National Kidney and Transplant Institute from January 2007 to December 2011
    Benavidez, Joel
    Parayno, Adolfo C.
    Mejes, Marc Anter E.
    Purugganan, Benito V. C.
    TRANSPLANTATION, 2016, 100 (07) : S698 - S699
  • [32] Induction therapy in kidney transplantation using kidney from expanded criteria donor: long term results comparing anti-IL2 receptor antibody and anti-thymocyte globulin.
    Lee, Kyo Won
    Park, Jae Berm
    Kim, Min Jung
    TRANSPLANTATION, 2019, 103 (11) : S78 - S78
  • [33] Long-term results (10 years) of a prospective trial comparing Lo-tact-1 monoclonal antibody and anti-thymocyte globulin induction therapy in kidney transplantation
    Beaudreuil, S.
    Durrbach, A.
    Noury, J.
    Ducot, B.
    Kriaa, F.
    Bazin, H.
    Charpentier, B.
    TRANSPLANT INTERNATIONAL, 2006, 19 (10) : 814 - 820
  • [34] INVIVO INHIBITION OF MURINE INTERLEUKIN-2-PRODUCING HELPER T-CELLS - COMPARATIVE EFFECTS OF ANTI-LYT-1 MONOCLONAL-ANTIBODY AND POLYCLONAL ANTI-THYMOCYTE SERA
    ROSENBERG, JL
    SWAIN, SL
    SOBOL, RE
    DUTTON, RW
    TRANSPLANTATION PROCEEDINGS, 1985, 17 (01) : 1001 - 1002
  • [35] Effect of Interleukin-2 Receptor Antibody Induction Therapy on Survival in Renal Transplant Patients Receiving Tacrolimus
    Ali, Hatem
    Sharma, Ajay
    Halawa, Ahmed
    AMERICAN JOURNAL OF NEPHROLOGY, 2020, 51 (05) : 366 - 372
  • [36] CYCLOSPORINE POTENTIATES THE IMMUNOSUPPRESSIVE EFFECTS OF ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODY THERAPY
    KUPIECWEGLINSKI, JW
    HAHN, HJ
    KIRKMAN, RL
    VOLK, HD
    MOUZAKI, A
    DISTEFANO, R
    TELLIDES, G
    DALLMAN, M
    MORRIS, PJ
    STROM, TB
    TILNEY, NL
    DIAMANTSTEIN, T
    TRANSPLANTATION PROCEEDINGS, 1988, 20 (02) : 207 - 216
  • [37] Induction With Anti-Thymocyte Globulin (r-ATG) and Delayed Calcineurin Inhibitor Therapy in Patients With Acute Renal Failure Dysfunction Pre-Liver Transplant Allows for Sustained Renal Recovery Post Transplant.
    Presser, N.
    Watson, M.
    Bollinger, J.
    Fujiki, M.
    Diago, T.
    Aucjeo, F.
    Quintini, C.
    Hashimoto, K.
    Kelly, D.
    Winans, C.
    Miller, C.
    Fung, J.
    Eghtesad, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 709 - 709
  • [38] Induction With Anti-Thymocyte Globulin (r-ATG) and Delayed Calcineurin Inhibitor Therapy in Patients With Acute Renal Failure Dysfunction Pre-Liver Transplant Allows for Sustained Renal Recovery Post Transplant.
    Presser, N.
    Watson, M.
    Bollinger, J.
    Fujiki, M.
    Diago, T.
    Aucjeo, F.
    Quintini, C.
    Hashimoto, K.
    Kelly, D.
    Winans, C.
    Miller, C.
    Fung, J.
    Eghtesad, B.
    TRANSPLANTATION, 2014, 98 : 709 - 709
  • [39] Rabbit anti-thymocyte globulin (rATG) versus IL-2 receptor antagonist induction therapies in tacrolimus-based immunosuppression era: a meta-analysis
    Hatem Ali
    Karim M. Soliman
    Ihab Shaheen
    Jon Jin Kim
    Mohsen El Kossi
    Ajay Sharma
    Ravi Pararajasingam
    Ahmed Halawa
    International Urology and Nephrology, 2020, 52 : 791 - 802
  • [40] Quadruple induction therapy including antithymocyte globulin or interleukin-2 receptor antibody or FK 506-based induction therapy after liver transplantation
    Lohmann, R
    Langrehr, JM
    Klupp, J
    Neumann, U
    Guckelberger, O
    Müller, AR
    Nüssler, NC
    Jonas, S
    Lang, M
    Settmacher, U
    Bechstein, WO
    Neuhaus, PJ
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 380 - 380
12345